Key result
Patients with unstable angina and hsTnT ≤99th percentile had a favorable 30-day outcome (0.8% MI, 0% cardiovascular death), though 180-day cardiovascular event rates reached 4.7%.
Why the study?
It was unclear whether single hsTnT ED presentation strategies to rule out myocardial infarction could also exclude unstable angina.
Do single measurement high-sensitivity troponin T strategies safely rule out unstable angina and predict short-term outcomes in patients presenting to the emergency department?
Cohort (n=240)
Do single measurement high-sensitivity troponin T strategies safely rule out unstable angina and predict short-term outcomes in patients presenting to the emergency department?
Single-measurement hsTnT strategies may allow safe ED discharge for suspected ACS due to favorable short-term prognosis, though patients over 60 with elevated CRP have substantial medium-term risk requiring timely outpatient assessment.
May support short-term rule-out with single hsTnT in UA; hypothesis-generating for medium-term risk in observational cohorts.
BACKGROUND: It is unclear if strategies to rule-out myocardial infarction (MI) based on a single high-sensitivity troponin T (hsTnT) measurement at the emergency department (ED) presentation may also exclude unstable angina. METHODS: We measured hsTnT ex-post on the admission frozen blood sample of 644 subjects with Braunwald IIIB CK-MB-negative unstable angina. This analysis included the 240 patients with hsTnT value ≤99th percentile reference limit (UA). We evaluated the clinical outcome of UA patients and the applicability of two rule-out strategies based on the combination of a non-ischemic ECG with (1) a single hsTnT value below the Limit-of-Detection (LoD), (2) a TIMI risk score ≤1. RESULTS: UA patients with hsTnT ≤99th percentile reference limit had a favorable 30-day outcome [0.8% MI, 0% cardiovascular death (CVD)], but the rate of CVD/MI at 180-day was 4.7%. Sensitivities for UA were 94.6% according to the 'TIMI ≤1-strategy' and 75.4% according to 'hsTnT-below-LoD-strategy', accounting for 5.4 and 24.6% missed diagnoses, respectively. A prognostic risk stratification to guide appropriate outpatient assessment in potential discharged unrecognized UA patients was developed: a risk score based on the combination of age >60 years and C-reactive protein >4.5 mg/L effectively stratified the 180-day CVD/MI occurrence: 0, 2.5 and 12.7% for score 0, 1 and 2 (log-rank = 0.001, C-statistic = 0.776). CONCLUSION: Single measurement hsTnT strategies, successfully tested to rule-out MI, may allow safe ED discharge of patients with a suspected acute coronary syndrome: even if UA may not be excluded, its short-term prognosis is favorable. UA patients with a C-reactive protein >4.5 mg/L and older than 60 years have a substantial medium-term cardiovascular risk and may benefit from a timely outpatient diagnostic assessment.
No takes yet. Share an insight, caveat, or question.
Gallone et al. (2020) conducted a cohort in Unstable angina (n=240). Single high-sensitivity troponin T (hsTnT) measurement rule-out strategies was evaluated on 30-day and 180-day myocardial infarction (MI) or cardiovascular death (CVD). Patients with unstable angina and hsTnT ≤99th percentile had a favorable 30-day outcome (0.8% MI, 0% cardiovascular death), though 180-day cardiovascular event rates reached 4.7%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: